•     Graduate from Uni-Mannheim & UNC, Shanghai Medical University.

•     20 + years of experience in the pharmaceutical industry, worked in MNC, Schering-Plough China, Praxair Asia, Fosun Pharma Group; Joined Shang Pharma as BD head, VP.

•     Drug development experience in the field of R&D , clinical trial management and market & commercial process; as well as the operational management, BD and investment and financing.

•     10+patents in China and PCT.

•    Pharmacology, The University of Hong Kong, PhD;University of Texas Southwestern Medical Center, Albert Einstein College of Medicine, Post-doctoral Fellow.

•    Worked for Genentech and Novartis. 20+ years early-stage drug development experience in the Biopharma field.

•    Research on the generation of antibodies targeting immune cell (hybridoma/phage panning) for cancer immunotherapy.

•    Develop comprehensive peptide array, biochemical and cell-based functional assays for antibody screening and characterization.

•     Professor in Oncology， Harvard Medical School.

•     20+ yrs leadership roles in biotech industry, i.e. Verastem Oncology (VP Translation Medicine), FemtoDx and On-Q-ty (CSO) , Daiamed, etc.